U.S. Insomnia Market: Key Factors Impacting The Future Growth MarketsandMarkets™ - Sep 26, 2018 The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion
U.S. Insomnia Market worth 4.24 Billion USD by 2021 MarketsandMarkets™ - Mar 31, 2017 U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root))